Synthesis of indolylalkoxyiminoalkylcarboxylates as leukotriene biosynthesis inhibitors. 1997

T Kolasa, and P Bhatia, and C D Brooks, and K I Hulkower, and J B Bouska, and R R Harris, and R L Bell
Abbott Laboratories, Abbott Park, IL 60064-3500, USA.

A series of substituted indolylalkoxyiminoalkylcarboxylates were found to be potent leukotriene biosynthesis inhibitors. The structure-activity relationships were investigated. Representative potent inhibitors identified were the quinolyl 3a (A-86885) and pyridyl 3b (A-86886) congeners with in vitro IC50s of 21 and 9 nM and in vivo leukotriene inhibition in the rat with oral ED50s of 0.9 and 1.7 mg/kg, respectively.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D007536 Isomerism The phenomenon whereby certain chemical compounds have structures that are different although the compounds possess the same elemental composition. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Isomerisms
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011804 Quinolines
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015289 Leukotrienes A family of biologically active compounds derived from arachidonic acid by oxidative metabolism through the 5-lipoxygenase pathway. They participate in host defense reactions and pathophysiological conditions such as immediate hypersensitivity and inflammation. They have potent actions on many essential organs and systems, including the cardiovascular, pulmonary, and central nervous system as well as the gastrointestinal tract and the immune system. Leukotriene

Related Publications

T Kolasa, and P Bhatia, and C D Brooks, and K I Hulkower, and J B Bouska, and R R Harris, and R L Bell
August 1983, Journal of medicinal chemistry,
T Kolasa, and P Bhatia, and C D Brooks, and K I Hulkower, and J B Bouska, and R R Harris, and R L Bell
November 1985, Pharmaceutical research,
T Kolasa, and P Bhatia, and C D Brooks, and K I Hulkower, and J B Bouska, and R R Harris, and R L Bell
January 1991, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques,
T Kolasa, and P Bhatia, and C D Brooks, and K I Hulkower, and J B Bouska, and R R Harris, and R L Bell
January 1998, Biochemical pharmacology,
T Kolasa, and P Bhatia, and C D Brooks, and K I Hulkower, and J B Bouska, and R R Harris, and R L Bell
June 2000, Journal of ethnopharmacology,
T Kolasa, and P Bhatia, and C D Brooks, and K I Hulkower, and J B Bouska, and R R Harris, and R L Bell
May 2017, Expert opinion on therapeutic patents,
T Kolasa, and P Bhatia, and C D Brooks, and K I Hulkower, and J B Bouska, and R R Harris, and R L Bell
May 1989, Journal of medicinal chemistry,
T Kolasa, and P Bhatia, and C D Brooks, and K I Hulkower, and J B Bouska, and R R Harris, and R L Bell
January 1985, Advances in prostaglandin, thromboxane, and leukotriene research,
T Kolasa, and P Bhatia, and C D Brooks, and K I Hulkower, and J B Bouska, and R R Harris, and R L Bell
January 1988, Journal of medicinal chemistry,
T Kolasa, and P Bhatia, and C D Brooks, and K I Hulkower, and J B Bouska, and R R Harris, and R L Bell
January 2023, ACS medicinal chemistry letters,
Copied contents to your clipboard!